Stay updated on IGN002 Dose-Escalation Study in NHL Clinical Trial

Sign up to get notified when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IGN002 Dose-Escalation Study in NHL Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page has a redesigned layout and styling, but core study details such as title, conditions, eligibility, outcomes, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-27T20:56:18.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    - Added a government-operations notice about potential delays and updated status; included links for details. - Updated software version from v3.1.0 to v3.2.0.
    Difference
    5%
    Check dated 2025-10-06T08:12:25.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:45:54.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the Back to Top link was removed. No other substantive changes detected.
    Difference
    0.3%
    Check dated 2025-09-14T23:13:56.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.3%
    Check dated 2025-09-07T19:50:51.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location related to Hemic and Lymphatic Diseases, while removing specific geographic details and resources related to Lymphosarcoma and Lymphoma.
    Difference
    3%
    Check dated 2025-08-31T12:38:43.000Z thumbnail image

Stay in the know with updates to IGN002 Dose-Escalation Study in NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.